(Q71169983)
Statements
Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients (English)
A L Børresen
1 reference
L A Akslen
1 reference
J E Varhaug
1 reference
H Johnsen
1 reference
S Geisler
B Smith-Sørensen